» Articles » PMID: 9271377

Control of Thrombopoietin-induced Megakaryocytic Differentiation by the Mitogen-activated Protein Kinase Pathway

Overview
Journal Mol Cell Biol
Specialty Cell Biology
Date 1997 Sep 1
PMID 9271377
Citations 41
Authors
Affiliations
Soon will be listed here.
Abstract

Thrombopoietin (TPO) is the major regulator of both growth and differentiation of megakaryocytes. We previously showed that both functions can be generated by TPO in the megakaryoblastic cell line UT7, in which murine Mpl was introduced, and are independently controlled by distinct regions of the cytoplasmic domain of Mpl. Particularly, residues 71 to 94 of this domain (deleted in the mutant mpl delta3) were found to be required for megakaryocytic maturation but dispensable for proliferation. We show here that TPO-induced differentiation in UT7 cells is tightly dependent on a strong, long-lasting activation of the mitogen-activated protein kinase (MAPK) pathway. Indeed, (i) in UT7-mpl cells, TPO induced a strong activation of extracellular signal-regulated kinases (ERK) which was persistent until at least 4 days in TPO-containing medium; (ii) a specific MAPK kinase (MEK) inhibitor inhibited TPO-induced megakaryocytic gene expression; (iii) the Mpl mutant mpl delta3, which displayed no maturation activity, transduced only a weak and transient ERK activation in UT7 cells; and (iv) TPO-induced megakaryocytic differentiation in UT7-mpl delta3 cells was partially restored by expression of a constitutively activated mutant of MEK. The capacity of TPO to trigger a strong and prolonged MAPK signal depended on the cell in which Mpl was introduced. In BAF3-mpl cells, TPO triggered a weak and transient ERK activation, similar to that induced in UT7-mpl delta3 cells. In these cells, no difference in MAPK activation was found between normal Mpl and mpl delta3. Thus, depending on the cellular context, several distinct regions of the cytoplasmic domain of Mpl and signaling pathways may contribute to generate quantitative variations in MAPK activation.

Citing Articles

A Novel Antithrombocytopenia Agent, , Promotes Megakaryopoiesis and Thrombopoiesis through the PI3K/AKT, MEK/ERK, and JAK2/STAT3 Signaling Pathways.

Chen W, Zhu L, Wang L, Zeng J, Wen M, Xu X Int J Mol Sci. 2022; 23(22).

PMID: 36430539 PMC: 9694118. DOI: 10.3390/ijms232214060.


Thrombocytopenia in chronic liver disease: Physiopathology and new therapeutic strategies before invasive procedures.

Gallo P, Terracciani F, Di Pasquale G, Esposito M, Picardi A, Vespasiani-Gentilucci U World J Gastroenterol. 2022; 28(30):4061-4074.

PMID: 36157107 PMC: 9403422. DOI: 10.3748/wjg.v28.i30.4061.


Identification of Modulators of HIV-1 Proviral Transcription from a Library of FDA-Approved Pharmaceuticals.

Sampey G, Iordanskiy S, Pleet M, DeMarino C, Romerio F, Mahieux R Viruses. 2020; 12(10).

PMID: 32977702 PMC: 7598649. DOI: 10.3390/v12101067.


Defective interaction of mutant calreticulin and SOCE in megakaryocytes from patients with myeloproliferative neoplasms.

Di Buduo C, Abbonante V, Marty C, Moccia F, Rumi E, Pietra D Blood. 2019; 135(2):133-144.

PMID: 31697806 PMC: 6952826. DOI: 10.1182/blood.2019001103.


CD110 promotes pancreatic cancer progression and its expression is correlated with poor prognosis.

Yan Z, Ohuchida K, Zheng B, Okumura T, Takesue S, Nakayama H J Cancer Res Clin Oncol. 2019; 145(5):1147-1164.

PMID: 30770989 DOI: 10.1007/s00432-019-02860-z.


References
1.
Komatsu N, Nakauchi H, Miwa A, Ishihara T, Eguchi M, Moroi M . Establishment and characterization of a human leukemic cell line with megakaryocytic features: dependency on granulocyte-macrophage colony-stimulating factor, interleukin 3, or erythropoietin for growth and survival. Cancer Res. 1991; 51(1):341-8. View

2.
Treisman R . Regulation of transcription by MAP kinase cascades. Curr Opin Cell Biol. 1996; 8(2):205-15. DOI: 10.1016/s0955-0674(96)80067-6. View

3.
Izquierdo M, Downward J, Graves J, Cantrell D . Role of protein kinase C in T-cell antigen receptor regulation of p21ras: evidence that two p21ras regulatory pathways coexist in T cells. Mol Cell Biol. 1992; 12(7):3305-12. PMC: 364544. DOI: 10.1128/mcb.12.7.3305-3312.1992. View

4.
Pelicci G, Lanfrancone L, McGlade J, Cavallo F, Forni G, Nicoletti I . A novel transforming protein (SHC) with an SH2 domain is implicated in mitogenic signal transduction. Cell. 1992; 70(1):93-104. DOI: 10.1016/0092-8674(92)90536-l. View

5.
Qui M, Green S . PC12 cell neuronal differentiation is associated with prolonged p21ras activity and consequent prolonged ERK activity. Neuron. 1992; 9(4):705-17. DOI: 10.1016/0896-6273(92)90033-a. View